Pancreatic Neoplasms: all 3,310 studies
Page 4 of 34. Open to participants first (910), then studies with results posted, then the rest; newest registration first within each.
- Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS MutationsRecruitingNCT06998940Phase 3
- The Vanguard Study: Testing a New Way to Screen for CancerRecruitingNCT06995898Not applicable
- Ivonescimab With GnP and SBRT in Patients With Metastatic Pancreatic Cancer (WGOG-PAN 004)Not yet recruitingNCT06991491Phase 2
- A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and FatigueRecruitingNCT06989437Phase 2/3
- Robotic vs Open PancreatoduodenectomyRecruitingNCT06981273Not applicable
- JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS AlterationRecruitingNCT06973564Phase 1/2
- A Clinical Study on the First-line Treatment of Metastatic Pancreatic Cancer With TQB2916 Injection Combined With Gemcitabine Hydrochloride for Injection and Paclitaxel for Injection (Albumin-bound Type)RecruitingNCT06962267Phase 2
- A Phase I/IIa Study of JAB-23E73 in Patients With Advanced Solid Tumors Harboring KRAS Gene AlterationRecruitingNCT06959615Phase 1/2
- Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic CancerRecruitingNCT06958328Phase 3
- A Phase III Study of Ivonescimab + Chemo With/Without AK117 in Metastatic Pancreatic CancerRecruitingNCT06953999Phase 3
- Intraoperative Hypotension in Pancreatoduodenectomy: A Randomized Trial of General Versus Combined AnesthesiaRecruitingNCT06953193Not applicable
- QL1706 Plus Chidamide, AG as First-line Treatment for Metastatic Pancreatic CancerRecruitingNCT06951997Phase 2
- The Safety and Effectiveness of Hyperthermic Intraperitoneal Chemotherapy Combined With Intravenous Chemotherapy for Peritoneal Metastatic Pancreatic Cancer, a Phase II Clinical TrialRecruitingNCT06946901Phase 2
- Validation of a miRNA Panel to Optimize Treatment Response in Patients With Metastatic Pancreatic Cancer (mirPANC 2)RecruitingNCT06945978
- A New Clinical Pathway for Personalized Management of Borderline Resectable and Locally Advanced Pancreatic CancerRecruitingNCT06944587
- A Study on Ivonescimab Plus Chemotherapy as Neoadjuvant Therapy for Borderline Resectable Pancreatic CancerRecruitingNCT06944106Phase 2
- Evaluate the Clinical Feasibility of a Novel Neoantigen-Reactive CD8+ T Cell (NART) Detection Technology for Postoperative MRD Surveillance of Pancreatic CancerNot yet recruitingNCT06941987
- NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic CancerRecruitingNCT06941857Phase 2
- Laparoscopic Versus Robot-assisted Left-sided Pancreatectomy for Benign and Pre-malignant Lesions (DIPLOMA-3)RecruitingNCT06939023Not applicable
- AG Plus Nimotuzumab Sequential Irreversible Electroporation Ablation for Locally Advanced Pancreatic CancerNot yet recruitingNCT06938503Phase 2
- An Exploratory Clinical Study of HRS-4642 in Combination With Immunotherapy and Chemotherapy for Pancreatic CancerRecruitingNCT06938282Phase 2
- Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation System-RecruitingNCT06937996
- Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing ChemotherapyRecruitingNCT06937177Phase 2
- Effect of an Enhanced Recovery After Surgery Program on Outcomes After PancreatoduodenectomyRecruitingNCT06935448
- Early Phase Study of KESONOTIDE™in Participants With Solid TumoursRecruitingNCT06926075Phase 1/2
- Adebrelimab Combined With AG Regimen in Patients With Unresectable Locally Advanced or Metastatic Pancreatic CancerNot yet recruitingNCT06916975Phase 2
- Tamoxifen for Advanced Solid Pseudopapillary Tumor of the PancreasRecruitingNCT06914674Phase 2
- Antecolic Versus Retrocolic Gastrojejunostomy During Whipple's ProcedureRecruitingNCT06914349Not applicable
- A Study of mRNA Vaccines AK154 Monotherapy or in Combination With AK104/AK112,and Sequential mFOLFIRINOX in Surgically Resected PDACNot yet recruitingNCT06913218Phase 1
- IDOV-Immune for Advanced Solid TumorsRecruitingNCT06910657Phase 1
- A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic AlterationsRecruitingNCT06906562Phase 2
- A Phase I Clinical Study of IX001 TCR-T Injection in the Treatment of Advanced Pancreatic Cancer Patients With KRAS G12V MutationRecruitingNCT06898385Phase 1
- Gemcitabine Plus Nab-paclitaxel as Switch Maintenance Versus Continuation of Modified FOLFIRINOX as 1st Line Chemotherapy in Patients With Advanced Pancreatic Cancer.RecruitingNCT06897644Phase 3
- e-Health Psychosocial Stress and Symptom Management (ePSMI) for Pancreatic Cancer PatientsRecruitingNCT06893276Not applicable
- Personalized Tumor Neoantigen MRNA Therapy Adjuvant Treatment for Postoperative Pancreatic Cancer.Not yet recruitingNCT06888674Phase 1/2
- Personalized Tumor Neoantigen MRNA Therapy for Advanced Pancreatic Cancer.Not yet recruitingNCT06888648Phase 1/2
- Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including MesotheliomaRecruitingNCT06885697Phase 1
- A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) ProductsEnrolling by invitationNCT06885424
- A Phase I Study of LXP1788 Injection with Advanced Solid Tumors.RecruitingNCT06883539Phase 1
- Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid TumorsAvailableNCT06872489
- A Study of JMT203 in Patients With Cancer CachexiaRecruitingNCT06868849Phase 1/2
- Neoadjuvant Chemotherapy for Elderly with Pancreatic Head CancerNot yet recruitingNCT06868693
- A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Advanced Pancreatic CancerNot yet recruitingNCT06866977Phase 1/2
- The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic CancerRecruitingNCT06861088Phase 3
- Effects of Peptamen 1.6 in Malnourished Patients (or at Risk) With Pancreatic Neoplasia Undergoing Cephalic Pancreaticoduodenectomy (CPD): A Mechanistic StudyRecruitingNCT06852014Not applicable
- Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic CancerRecruitingNCT06850623Phase 2
- Assessment of the Prognosis of Pancreatic Cancer Patients Using 3D MRERecruitingNCT06849063
- Chemoradiotherapy in Elderly Patients with Locally Advanced Pancreatic Cancer (70+).Not yet recruitingNCT06844773
- Adapted Guided Stereotactic Body Radiotherapy Combined With Chemotherapy and Enhancement of Novel Drug Ivonescimab for Pancreatic Cancer (ASCEND)RecruitingNCT06844422Phase 1/2
- Clinical Application of PET Imaging Targeting MSLN in Malignant TumorsRecruitingNCT06843629
- The Miami "EMPIRE" Trial - Eradication of Metastatic Pancreatic Cancer With Immuno-RadiationRecruitingNCT06843551Phase 2
- Clinical Study of Carbon Ion Radiotherapy for Pancreatic Cancer.RecruitingNCT06840067Not applicable
- A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS MutationsRecruitingNCT06835569Phase 1
- A Study of GC203 TIL in PDCA (RJ)RecruitingNCT06828328Early Phase 1
- Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early DiagnosisRecruitingNCT06822413
- Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid TumorsRecruitingNCT06821048Phase 1
- Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid TumorsRecruitingNCT06819215Phase 1/2
- CAR-NK Cells (CL-NK-001) in Pancreatic CancerRecruitingNCT06816823Phase 1
- Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic FistulaRecruitingNCT06807437Phase 3
- Surveillance of Pancreatic Health After Diabetes DiagnosisRecruitingNCT06803771Not applicable
- ToPanc Trial: Survival After Total Versus Partial Pancreaticoduodenectomy for Adenocarcinoma of the Pancreatic Head, Distal Cholangiocarcinoma, and Ampullary CancerRecruitingNCT06801899Not applicable
- Gut Microbiota Analysis in Patients Undergoing Duodencephalopancreasectomy for Pancreatic CancerRecruitingNCT06800469Not applicable
- Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard TreatmentsRecruitingNCT06799637Phase 1/2
- Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic CancerRecruitingNCT06782932Phase 1/2
- Liposomal Irinotecan + Oxaliplatin + Bevacizumab Versus Liposomal Irinotecan + 5-FU/LVRecruitingNCT06782685Phase 1/2
- Maintenance Chemotherapy With S-1 vs. Observation After Adjuvant Therapy for Resected Pancreatic Cancer With High Risk of Recurrence/MetastasisNot yet recruitingNCT06779318Phase 4
- Role of Exosomes in Pancreatic Cancer ProgressionRecruitingNCT06777030
- Structured Follow-up Intervention on Glucose Status After Pancreatic Cancer SurgeryEnrolling by invitationNCT06774170Not applicable
- HRS-4642 With Nimotuzumab and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer PatientsRecruitingNCT06770452Phase 2
- Clinical Study of TQB2868 Injection Combined With Anlotinib Capsule and Chemotherapy in the First-line Treatment of Metastatic Pancreatic NeoplasmsRecruitingNCT06767813Phase 2
- Assessing Pancreatic Fistula Rates After Distal Pancreatectomy Using AEON EndostaplerRecruitingNCT06764134
- In This Study, a Retrospective Analysis Was Conducted to Explore the Risk Factors for Patients Undergoing Pancreaticoduodenal Surgery (PD) to Achieve TO, and a Nomogram Prediction Model Was Further Established to Promote the Standardization and Standardization of PD Surgical Quality Evaluation.RecruitingNCT06763250
- mFOLFIRINOX Plus Anlotinib and Sintilimab for Advanced Pancreatic CancerRecruitingNCT06761027Phase 1/2
- A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)RecruitingNCT06760819Phase 2
- PREVENPANC Project: a Spanish Multicenter Study for Pancreatic Cancer PreventionNot yet recruitingNCT06760741
- A Clinical Study of CHT102 in MSLN-Positive Advanced Pancreatic CancerRecruitingNCT06760364Phase 1
- Metronomic Capecitabine with Camrelizumab and Apatinib Mesylate for Treatment of Advanced Pancreatic CancerNot yet recruitingNCT06759090Phase 2
- A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Resectable Pancreatic CancerRecruitingNCT06758544Phase 1/2
- DOVIPA, a Study Evaluating Efficacy and Safety of DOstarlimab and VItamin D3 With mFOLFIRINOX in PAncreatic CancerRecruitingNCT06757244Phase 2
- Reinforced Pancreaticojejunostomy With or Without glubran2RecruitingNCT06756074Phase 2
- Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Advanced Pancreatic CancerRecruitingNCT06755359Not applicable
- Validation of Joint-AI in Diagnosing Pancreatic Solid LesionsNot yet recruitingNCT06753318Not applicable
- Expanded Access Program (EAP) Designed to Provide Access to Botensilimab and Balstilimab Before Regulatory ApprovalAvailableNCT06751524
- A Study of DM002 in Patients With Advanced Solid TumorsRecruitingNCT06751329Phase 1/2
- Neutrophil-to-lymphocyte Ratio and CA 19.9 as Predictors of Perineural Invasion in Pancreatic CancerRecruitingNCT06747481
- Personalized Education and Genetic Counseling to Increase Genetic Testing in Patients With a Known Family History of Pancreatic CancerEnrolling by invitationNCT06744595Not applicable
- Oral Immunonutrition Therapy to Reduce Acute Toxicity After Neoadjuvant Chemoradiotherapy Pancreatic Cancer PatientsRecruitingNCT06736678Not applicable
- Phase I/II Study: Allogeneic NK-cell Therapy With Chemotherapy for Post-Surgery PDA or Cholangiocarcinoma PatientsRecruitingNCT06730009Phase 1/2
- A Study of MGC028 in Participants With Advanced Solid TumorsRecruitingNCT06723236Phase 1
- Study of Adjuvant Nimotuzumab Combined with Nab-paclitaxel+ Gemcitabine in EGFR-positive Pancreatic CancerRecruitingNCT06722911Phase 2
- Target-specific immunoPET Imaging of Digestive System CarcinomaRecruitingNCT06715839Not applicable
- Standard or Prolonged Neoadjuvant Chemotherapy Before Surgery for BR/LAPCRecruitingNCT06714604Phase 3
- Observational Copenhagen Pancreatic Cancer StudyRecruitingNCT06713525
- Endocrine, Metabolic, Inflammatory Biomarkers to Identify Highgrade Dysplasia/invasive Carcinoma in Patients with IPMN of the PancreasRecruitingNCT06706700
- Convertases and Pancreatic Cancer: Cohort of Patients Treated for Pancreatic AdenocarcinomaRecruitingNCT06705335
- Conventional Partial Pancreatoduodenectomy Versus an Extended Pancreatoduodenectomy for Pancreatic Head CancersNot yet recruitingNCT06703905Not applicable
- Second-line Irinotecan Liposome Combination Regimen for Irinotecan-treated Pancreatic CancerNot yet recruitingNCT06700603Phase 2
- Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic CancerRecruitingNCT06698458Not applicable
- A Phase 2 Study of Zanidatamab in Patients With HER2-expressing TumorsRecruitingNCT06695845Phase 2
- Stereotactic Body Radiation Therapy for Inoperable Non-metastasized Pancreatic AdenocarcinomaRecruitingNCT06691425Not applicable